Faruqi & Faruqi, LLP is Investigating FedEx Corporation (FDX) on Behalf of its Shareholders
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at FedEx Corporation (“FedEx” or the “Company”) (NYSE: FDX).
The investigation focuses on whether the Company and its officers breached their fiduciary duties by causing or allowing FedEx to engage in improper conducted related to the shipment of illegal pharmaceuticals.
On July 10, 2014, FexEx was indicted by a federal grand jury in San Francisco in a 15-count indictment which included drug trafficking and the conspiracy to distribute controlled substances. The Company’s alleged misconduct occurred despite the fact that United States drug enforcement officials had repeatedly warned the Company to cease the illicit transportation of pharmaceutical drugs.
If you currently own FedEx stock and have owned it since 2004 and would like to discuss your legal rights, please contact us by calling Stuart Guber toll free at (215) 277-5770 or by sending an e-mail to email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding FedEx’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Please tell us about yourself by completing the form below and we will provide you with additional
information on how to join the Action.
* The submission of this form does not create an attorney-client relationship.
Stuart J. Guber
Faruqi & Faruqi, LLP
101 Greenwood Avenue Suite 600
Jenkintown, PA 19046
Tel: (215) 277-5770
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.